Strides Pharma to spin off contract development unit

Strides Pharma Science on Monday said it would spin off its contract development and manufacturing organisation (CDMO) and soft gelatin business into a new entity which would list in the next 12-16 months.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/NhLDbt5
via IFTTT